> ## Content Index
> Fetch the complete content index at: https://www.bullished.co/llms.txt
> Use this file to discover other available public pages before exploring further.

# State Street Holds 5% Of Dexcom — It Says The Stake Is Passive
- URL: https://www.bullished.co/state-street-holds-5-of-dexcom-it-says-the-stake-is-passive-04834205/
- Published: 2026-11-10T12:53:30.000Z
- Updated: 2026-11-10T12:53:30.000Z
- Description: The reported holding covered 18,917,265 shares, with shared voting authority over a smaller portion.
- Author: Matteo Parrino
- Tags: SEC Filings, DXCM, Industry: Healthcare

State Street reported a [5% stake](https://www.sec.gov/Archives/edgar/data/0000093751/000009375126000645/xslSCHEDULE%5F13G%5FX01/primary%5Fdoc.xml?ref=bullished.co) in [Dexcom](https://www.bullished.co/tag/dxcm/), which makes wearable glucose-monitoring sensors, and certified that it was not seeking to influence the company's control. Its passive ownership disclosure filed Tuesday covered 18,917,265 common shares as of September 30, 2026.

## Ownership And Voting Power Differ

State Street's reported ownership and its ability to vote the stock cover different amounts. It had [shared voting authority](https://www.sec.gov/Archives/edgar/data/0000093751/000009375126000645/xslSCHEDULE%5F13G%5FX01/primary%5Fdoc.xml?ref=bullished.co) over 12,153,366 shares and shared authority to sell or otherwise dispose of 18,896,988 shares. It had no sole authority to vote or dispose of shares.

State Street certified that the securities were bought and held as part of its ordinary business, rather than to change or influence Dexcom's control. The certification also covered participation in transactions aimed at influencing control, with an exception for activities solely connected to a nomination under the SEC rule identified in the disclosure.

## Wearable Sensors, With A Penang Base

Dexcom's sensors transmit glucose measurements to a receiver or compatible mobile device. People managing diabetes and metabolic health use the systems, as do the caregivers and clinicians supporting them.

Its products include G7, G7 15 Day and Dexcom ONE+, which is sold in several European countries. Stelo is an over-the-counter biosensor for adults with prediabetes or Type 2 diabetes who do not use insulin. Dexcom also connects its sensors with devices made by insulin pump and pen manufacturers.

Most revenue has come from the United States. Dexcom sells through distributors and a direct team serving health care professionals in North America and selected international markets, and mainly manufactures in Mesa, Arizona, and Penang, Malaysia.

Dexcom was among [recent investors](https://theedgemalaysia.com/article/special-report-medical-devices-industry-penangs-hidden-gem?ref=bullished.co) in Penang's medical-device industry. The cluster developed partly from the state's electrical and electronics sector, whose manufacturers could transfer production skills to medical devices.

Ching Choon Siong, executive director of the Association of Malaysian Medical Industries, identified [competitive costs](https://theedgemalaysia.com/article/special-report-medical-devices-industry-penangs-hidden-gem?ref=bullished.co), infrastructure and workforce skills as reasons investors such as Dexcom were attracted to Penang.

The 5% ownership figure describes State Street's position at September 30; Tuesday was the date it filed the disclosure.

Learn

- [What a Reverse Termination Fee Means: Who Pays When a Merger Collapses →](https://www.bullished.co/learn/reverse-termination-fee-meaning/)  
A reverse termination fee is paid by the buyer to the target if a merger fails on agreed terms. See how it differs from a break-up fee, with live deal examples.
- [How To Read A Merger Proxy: A Checklist For Shareholders Facing A Vote →](https://www.bullished.co/learn/merger-proxy-statement-how-to-read/)  
Facing a merger vote? Read the proxy in this order: price and payment, vote date and threshold, board background, synergy claims, then closing conditions.

### Sources

- [SCHEDULE 13G — STATE STREET CORPORATION re: DEXCOM INC (DXCM)](https://www.sec.gov/Archives/edgar/data/0000093751/000009375126000645/xslSCHEDULE%5F13G%5FX01/primary%5Fdoc.xml?ref=bullished.co) — SEC EDGAR
- [Special Report: Medical devices industry is Penang’s hidden gem](https://theedgemalaysia.com/article/special-report-medical-devices-industry-penangs-hidden-gem?ref=bullished.co) — The Edge Malaysia

### More on DexCom

- [Dexcom Finished A $1 Billion Buyback In Nine Months, Then Approved Another](https://www.bullished.co/dexcom-finished-a-1-billion-buyback-in-nine-months-then-approved-another-f22c2a28/)
- [DexCom CEO Still Expects A Medicare Coverage Decision This Year, Backed By Connect Trial](https://www.bullished.co/dexcom-ceo-still-expects-a-medicare-coverage-decision-this-year-backed-by-connect-trial-35fa42c7/)
- [DexCom Says Lost PBM Coverage Is Under 4% Of U.S. Revenue And Won't Dent 2027 Much](https://www.bullished.co/dexcom-says-lost-pbm-coverage-is-under-4-of-u-s-revenue-and-wont-dent-2027-much-20d90b52/)

[All DexCom (DXCM) coverage →](https://www.bullished.co/tag/dxcm/)